Cadonilimab
AK104-IIT-C-E-0195
Unknown small_molecule active
Quick answer
Cadonilimab for Locally Advanced Esophageal Squamous Cell Carcinoma is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Locally Advanced Esophageal Squamous Cell Carcinoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active